Abstract
Biological research in the field of suicidology is strictly linked to biological aspects of depressive illness. About half of suicides are retrospectively diagnosed as having suffered from depression, while most of them had had depressive symptoms prior to death (Beskow 1979; Van Praag 1982). The biochemical mechanisms at the basis of depressive illness are not yet fully understood. Several studies suggest an involvement of noradrenaline and serotonin. Low levels of serotonin, or its metabolite 5-hydroxyindoleacetic acid (5-HIAA), have been observed in the brain of suicides (Lloyd et al. 1974). Van Praag (1977) suggested that low concentrations of 5-HIAA in the CNS could be a marker for the vulnerability to depression. Several groups have studied the relationship between suicidal behavior and the concentrations of 5-HIAA in the CNS (Åsberg et al. 1976; Träskman et al. 1981; Van Praag 1982; Roy et al. 1984). Many, but not all of the investigators, observed a correlation between low levels of 5-HIAA and suicidally. Considering that 2% of those who attempt suicide are successful, it is important to predict the risk of suicide to prevent it.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arora RC, Meltzer HY (1984) Imipramine binding in subpopulations of normal human blood platelets. Biol Psychiatry 19:257–262
Arora RC, Kregel L, Meltzer HY (1983) Seasonal variation of serotonin uptake in normal controls and depressed patients. Biol Psychiatry 19:795–804
Asarch KB, Shih JC, Kulcsar A (1980) Decreased 3H-imipramine binding in depressed males and females. Commun Psychopharmacol 4:425–432
Åsberg M, Traskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 33:1193–1197
Baron M, Barkai A, Gruen R, Kowalik S, Quitkin F (1983) 3H-imipramine binding sites in unipolar depression. Biol Psychiatry 18:1403–1409
Baron M, Barkai A, Gruen R, Peselow E, Fieve RR, Quitkin F (1986) Platelet 3H-imipramine binding sites in affective disorders: trait versus status characteristics. Am J Psychiatry 143:711–717
Berrettini WH, Nurnberger JI, Post RM, Gershon ES (1982) Platelet 3H-imipramine binding in euthymic bipolar patients. Psychiatry Res 7:215–219
Beskow J (1979) Suicide and mental disorder in Swedish men. Acta Psychiatr Scand [Suppl] 277
Braddock LE, Cowen PS, Elliot SM, Frazer S, Stump K (1984) Changes in the binding to platelets of 3H-imipramine and 3H-yohimbine in normal subjects taking amitryptiline. Neuropharmacol 23:285–288
Briley MS, Raisman R, Langer SZ (1979) Human platelets possess high-affinity binding sites for 3H-imipramine. Eur J Pharmacol 58:347–348
Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980) Tritiated impramine binding sites are decreased in platelets from untreated depressed patients. Science 209:303–305
Briley MS, Raisman R, Arbilla S, Casadamont M, Langer SZ (1982) Concomitant decrease in 3H-imipramine binding in cat brain and platelets after chronic treatment with imipramine. Eur J Pharmacol 81:309–314
Buchsbaum MS, Coursey ED, Murphy DL (1976) The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science 194:339–341
Coppen A, Swade C, Wood K (1978) Platelet 5-hydroxytryptamine accumulation in depressive illness. Clin Chim Acta 87:165–168
Crow T (1985) Monoamine neurons and reward: can they be related to clinical syndrome? Proc 14th Ann Meeting Soc Biol Psychiatry. Dallas, May 15–19
Egrise D, Desmedt D, Schoutens A, Mendlewicz J (1983) Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man. Neuropsychobiol 10:101–102
Friedl W, Propping P, Weck B (1983) 3H-imipramine binding in human platelets. Influence of varying proportions of intact platelets in membrane preparations on binding. Psychopharmacol 80:96–99
Gentsch G, Lichsteiner M, Feer H (1984) Regional distribution of 3H-imipramine and 3H-cyanoimipramine binding in rat brain tissues: effect of long-term antidepressant administration. J Neural Transmission 59:257–261
Gentsch G, Lichsteiner M, Gastpar M, Gastpar G, Feer H (1985) 3H-imipramine binding sites in platelets of hospitalized psychiatric patients. Psychiatry Res 14:177–187
Gottfries CG, Knorring L von, Oreland L (1980) Platelet monoamine oxidase activity in mental disorders. II. Affective disorders and suicidal behavior. Prog Neuropsychopharmacol 4:185–192
Healy D, O’Halloran A, Carney PA, Leonard BE (1986) Platelet 5-HT uptake in delusional and non delusional depression. J Affective Disord 10:233–239
Hrdina PA, Lapiere YA, Horn ER, Bakish D (1986) Platelet 3H-imipramine binding: a possible predictor of response to antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 9:619–623
Langer SZ, Briley MS, Raisman R, Henry JF, Morselli PL (1980) Specific 3H-imipramine binding in human platelets: influence of age and sex. Naunyn Schmiedebergs Arch Pharmacol 313:189–194
Langer SZ, Raisman R (1983) High-affinity binding of 3H-imipramine and 3H-desipramine: biochemical tools for studies in depression. Life Sci 29:211–220
Langer SZ, Sechter D, Loo H, Raisman R, Zarifian E (1986) Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depression. Arch Gen Psychiatry 43:949–952
Lewis DA, McChesney C (1985) Tritiated imipramine binding distinguishes among subtypes of depression. Arch Gen Psychiatry 42:485–488
Lewis DA, Noyes RJ, Coryell W, Clancy S (1985) Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. Psychiatry Res 16:2–9
Lloyd KG, Farley IJ, Deck JHN, Hornykiewicz O (1974) Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brain stem of suicide victims and control patients. Adv Biochem 11:387–398
Marazziti D, Giusti P, Rotondo A, Placidi GF, Pacifici GM (1987) Imipramine receptors in human platelets: effect of age. Clin Pharmacol Res VII (2): 145–148
Mellerup EG, Plenge P, Rosenberg R (1982) 3H-imipramine binding sites in platelets from psychiatric patients. Psychiat Res 7:221–227
Meltzer HY, Arora RC, Baber R, Tricou BJ (1981) Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry 38:1322–1326
Meltzer HY, Arora RC, Robertson A, Lowy M (1984) Platelet 3H-imipramine binding and platelet 5-HT uptake in affective disorders and schizophrenia. Clin Neuropharmacol [Suppll] 7:320–321
Meyerson LR, Wennogle LP, Abel MS, Coupet J, Lippa AS, Rau CE, Beer B (1982) Human brain receptor alterations in suicide victims. Pharmacol Biochem Behav 17:157–163
Paul SM (1986) Serotonin reuptake in platelets and human brain: clinical implications. Proc WPA Regional Symposium, Copenhagen, 19–22 May
Paul SM, Rehavi M, Skolnick P, Goodwin FK (1980) Demonstration of specific high-affinity binding sites for 3H-imipramine in human platelets. Life Sci 26:953–959
Paul SM, Rehavi M, Rice KC, Ittah Y, Skolnick P (1981 a) Does high affinity 3H-imipramine binding label serotonin reuptake sites in brain and platelets? Life Sci 28:2753–2760
Paul SM, Rehavi M, Skolnick P, Ballenger JC, Goodwin FK (1981 b) Depressed patients have decreased binding of tritiated imipramine to platelet serotonin transporter. Arch Gen Psychiatry 38:1315–1317
Perry EK, Marshall EF, Blessed G, Tomlinson BE, Perry RH (1983) Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry 142:188–192
Raisman R, Briley R, Langer SZ (1979) High affinity imipramine binding in rat cerebral cortex. Eur J Pharmacol 54:307–308
Raisman R, Secther D, Briley MS, Zarifian E, Langer SZ (1981) High affinity 3H-imipramine binding in platelets from untreated and treated patients compared to healthy volunteers. Psychopharmacology 75:368–371
Raisman R, Briley MS, Bouchami F, Sechter D, Zarifian E, Langer SZ (1982) 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers. Psychopharmacology 77:332–335
Rehavi M, Paul SM, Skolnick P, Goodwin FK (1980) Demonstration of specific high-affinity binding sites in human brain. Life Sci 26:2273–2276
Roy P, Post RM, Rubinow DR, Linnoila M, Savard R, Davis D (1984) CSF 5-HIAA and personal and family history of suicide in affectively ill patients: a negative study. Psychiatry Res 10:263–274
Stahl SM (1977) The human platelets. A diagnostic and research tool of the study of biogenic amines in psychiatric and neurological disorders. Arch Gen Psychiatry 34:509–516
Stanley M, Virgilio J, Gershon S (1982) Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1377–1379
Suranyi-Cadotte BE, Wood PL, Nair NPV, Schwartz G (1982) Normalization of platelet 3H-imipramine binding in depressed patients during remission. Eur J Pharmacol 85:357–358
Suranyi-Cadotte BE, Quirion R, McQuide P (1984) Platelet 3H-imipramine binding: a state dependent marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 8:731–741
Traskman L, Åsberg M, Bertilsson L, Sjostrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631–636
van Praag HM (1977) Significance of biochemical parameters in the diagnosis, treatment and prevention of depressive disorders. Biol Psychiatry 8:311–325
van Praag HM (1982) Depression, suicide and the metabolism of serotonin in the brain. J Affective Disord 4:275–290
Waegner A, Aberg-Wistedt A, Åsberg M, Ekqvist B, Martenson B, Montero D (1985) Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls. Psychiatry Res 16:131–139
Weizman A, Carmi M, Hermesh H, Shahar A, Apter A, Tyano S, Rehavi M (1986 a) Highaffinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am J Psychiatry 143:335–339
Weizman R, Carmi M, Tyano S, Apter A, Rehavi M (1986 b) High-affinity 3H-imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sci 38:1235–1242
Wennogle LP, Meyerson LR (1984) Serotonin modulates the dissociation of 3H-imipramine from human platelet recognition sites. Eur J Pharmacol 86:303–307
Whitaker PM, Warsh IJ, Stancer HC, Persad E, Vint CK (1984) Seasonal variation in platelet 3H-imipramine binding: comparable values in control and depressed populations. Psychiatry Res 11:127–131
Wood PL, Suranyi-Cadotte BE, Schwartz G, Nair PV (1983) Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogenous pathogenesis. Biol Psychiatry 18:715–719
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Marazziti, D., Pacifici, G.M. (1988). Review of Imipramine Binding in Platelets from Psychiatric Patients: Its Relevance to the Biology of Suicide. In: Möller, HJ., Schmidtke, A., Welz, R. (eds) Current Issues of Suicidology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73358-1_37
Download citation
DOI: https://doi.org/10.1007/978-3-642-73358-1_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73360-4
Online ISBN: 978-3-642-73358-1
eBook Packages: Springer Book Archive